Corindus Envisions Network Of CorPath Robots For Remote Neurovascular And Coronary Interventions
Executive Summary
The physician who led the first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
You may also be interested in...
Robocath Updates Progress With R-One Robotic Coronary Intervention Platform
French company Robocath believes its R-One robotic catheter intervention system will make coronary interventions more efficient for hospitals and safer for interventionalists. Robocath is sponsoring a 60-patient European trial of coronary interventions with R-One.
Siemens Healthineers In Line With Future Trends As It Mines Workflow And Outcomes Seams
Siemens Healthineers ̶ an engineering company by background – sees itself well positioned to benefit from the markets’ movement towards digital, workflows, robotics and minimally-invasive procedures. As such, it has advantages over pharma companies in being able to deliver better patient outcomes at lower cost and more effectively.
Siemens Snaps Up Corindus Vascular Robotics For $1.1Bn
Siemens Healthineers AG has signed a billion-dollar deal to merge with US firm Corindus Vascular Robotics, expanding the German company's advanced therapies business.
Need a specific report? 1000+ reports available
Buy Reports